acc41801 |
Heterogeneous nuclear ribonucleoprotein A1 |
phosphorylation |
Ser4 |
human |
Skin Cancer |
SKMEL-28 |
CB556 |
Positive |
3.0 (Low)
|
PXD049299
|
acc41802 |
Dolichol-phosphate mannosyltransferase subunit 1 |
phosphorylation |
Ser9 |
human |
Skin Cancer |
SKMEL-28 |
CB556 |
Negative |
3.0 (Low)
|
PXD049299
|
acc41803 |
Protein disulfide-isomerase A6 |
phosphorylation |
Ser428 |
human |
Skin Cancer |
SKMEL-28 |
CB556 |
Positive |
3.0 (Low)
|
PXD049299
|
acc41804 |
AT-rich interactive domain-containing protein 3C |
oxidation |
Met127 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41805 |
AT-rich interactive domain-containing protein 3A |
oxidation |
Met252 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41806 |
"Beta-1,4-glucuronyltransferase 1" |
oxidation |
Met90 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41807 |
U5 small nuclear ribonucleoprotein 200 kDa helicase |
oxidation |
Met963 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41808 |
Isocitrate dehydrogenase [NADP] cytoplasmic |
oxidation |
Met180 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Negative |
3.0 (Low)
|
PXD051299
|
acc41809 |
Importin-7 |
oxidation |
Met174 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Negative |
3.0 (Low)
|
PXD051299
|
acc41810 |
L-lactate dehydrogenase A chain |
oxidation |
Met204 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41811 |
L-lactate dehydrogenase A chain |
oxidation |
Met276 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41812 |
Cytochrome c oxidase subunit 2 |
oxidation |
Met152 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41813 |
Glyceraldehyde-3-phosphate dehydrogenase |
oxidation |
Met130 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Negative |
3.0 (Low)
|
PXD051299
|
acc41814 |
Glyceraldehyde-3-phosphate dehydrogenase |
oxidation |
Met133 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41815 |
Acyl-CoA-binding protein |
oxidation |
Met25 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Negative |
3.0 (Low)
|
PXD051299
|
acc41816 |
Pyruvate kinase PKM |
oxidation |
Met330 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Negative |
3.0 (Low)
|
PXD051299
|
acc41817 |
Elongation factor 1-beta |
oxidation |
Met155 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Negative |
3.0 (Low)
|
PXD051299
|
acc41818 |
"Isovaleryl-CoA dehydrogenase, mitochondrial" |
oxidation |
Met298 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41819 |
Polypyrimidine tract-binding protein 1 |
oxidation |
Met524 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41820 |
Exosome RNA helicase MTR4 |
oxidation |
Met726 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41821 |
Caspase-3 |
oxidation |
Met233 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Negative |
3.0 (Low)
|
PXD051299
|
acc41822 |
Fatty acid synthase |
oxidation |
Met687 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Negative |
3.0 (Low)
|
PXD051299
|
acc41823 |
Adenosine 5'-monophosphoramidase HINT1 |
oxidation |
Met96 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41824 |
Aldo-keto reductase family 1 member C2 |
oxidation |
Met16 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Negative |
3.0 (Low)
|
PXD051299
|
acc41825 |
Aldo-keto reductase family 1 member C1 |
oxidation |
Met16 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Negative |
3.0 (Low)
|
PXD051299
|
acc41826 |
"Actin, cytoplasmic 2" |
oxidation |
Met82 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Negative |
3.0 (Low)
|
PXD051299
|
acc41827 |
"Actin, cytoplasmic 2, N-terminally processed" |
oxidation |
Met82 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Negative |
3.0 (Low)
|
PXD051299
|
acc41828 |
Peptidyl-prolyl cis-trans isomerase A |
oxidation |
Met100 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Negative |
3.0 (Low)
|
PXD051299
|
acc41829 |
Importin subunit beta-1 |
oxidation |
Met842 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Negative |
3.0 (Low)
|
PXD051299
|
acc41830 |
Triokinase/FMN cyclase |
oxidation |
Met495 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41831 |
T-complex protein 1 subunit eta |
oxidation |
Met178 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41832 |
"Acetyl-CoA acetyltransferase, cytosolic" |
oxidation |
Met140 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41833 |
Mitochondrial disaggregase |
oxidation |
Met467 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41834 |
Chloride intracellular channel protein 4 |
oxidation |
Met43 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41835 |
Chloride intracellular channel protein 2 |
oxidation |
Met38 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41836 |
Chloride intracellular channel protein 5 |
oxidation |
Met199 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41837 |
Chloride intracellular channel protein 6 |
oxidation |
Met495 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41838 |
Soluble lamin-associated protein of 75 kDa |
oxidation |
Met198 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Negative |
3.0 (Low)
|
PXD051299
|
acc41839 |
Protein phosphatase 1 regulatory subunit 7 |
phosphorylation |
Ser24 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41840 |
Protein phosphatase 1 regulatory subunit 7 |
phosphorylation |
Ser27 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41841 |
Thioredoxin domain-containing protein 5 |
phosphorylation |
Ser195 |
human |
Liver Cancer |
HepG2 |
Sorafenib |
Positive |
3.0 (Low)
|
PXD051299
|
acc41842 |
Putative uncharacterized protein PIK3CD-AS1 |
acetylation |
Lys166 |
human |
Breast Cancer |
MCF10A |
Mn2L2 |
Negative |
3.0 (Low)
|
PXD051376
|
acc41843 |
Putative uncharacterized protein PIK3CD-AS1 |
acetylation |
Lys166 |
human |
Breast Cancer |
MCF10A |
PtDAPCl2 |
Negative |
3.0 (Low)
|
PXD051376
|
acc41844 |
U3 small nucleolar RNA-associated protein 15 homolog |
acetylation |
Lys5 |
human |
Breast Cancer |
MCF10A |
PtDAPCl2 |
Positive |
3.0 (Low)
|
PXD051376
|
acc41845 |
Putative uncharacterized protein PIK3CD-AS1 |
acetylation |
Lys166 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Negative |
3.0 (Low)
|
PXD051376
|
acc41846 |
Putative uncharacterized protein PIK3CD-AS1 |
acetylation |
Lys166 |
human |
Breast Cancer |
MCF7 |
Mn2L2Pt |
Negative |
3.0 (Low)
|
PXD051376
|
acc41847 |
Cytochrome P450 3A43 |
acetylation |
Lys168 |
human |
Breast Cancer |
MCF7 |
Mn2L2Pt |
Negative |
3.0 (Low)
|
PXD051376
|
acc41848 |
Putative uncharacterized protein PIK3CD-AS1 |
acetylation |
Lys166 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Negative |
3.0 (Low)
|
PXD051376
|
acc41849 |
U3 small nucleolar RNA-associated protein 15 homolog |
acetylation |
Lys5 |
human |
Breast Cancer |
MCF7 |
PtDAPCl2 |
Positive |
3.0 (Low)
|
PXD051376
|
acc41850 |
Ankyrin repeat domain-containing protein 18B |
oxidation |
Met606 |
human |
Breast Cancer |
MCF10A |
Mn2L2 |
Positive |
3.0 (Low)
|
PXD051376
|